Overcoming acquired resistance to cetuximab by dual targeting HER family receptors with antibody-based therapy
Mari Iida(University of Wisconsin–Madison), Deric L. Wheeler(University of Wisconsin–Madison)
Cited by 64
Related Papers
Regulation of Heparin-Binding EGF-Like Growth Factor by miR-212 and Acquired Cetuximab-Resistance in Head and Neck Squamous Cell Carcinoma
|PLoS ONE|2010|165
Mapping C-Terminal Transactivation Domains of the Nuclear HER Family Receptor Tyrosine Kinase HER3
|PLoS ONE|2013|27
AXL regulates neuregulin1 expression leading to cetuximab resistance in head and neck cancer
|BMC Cancer|2022|16
AXL Regulates Neuregulin1 Expression Leading to Cetuximab Resistance in Head and Neck Cancer
|Research Square|2021|1